{"id":8,"date":"2024-09-12T19:47:02","date_gmt":"2024-09-12T19:47:02","guid":{"rendered":"https:\/\/www-stg.nybcventures.com\/?page_id=8"},"modified":"2024-11-13T19:06:20","modified_gmt":"2024-11-13T19:06:20","slug":"home","status":"publish","type":"page","link":"https:\/\/www-stg.nybcventures.com\/","title":{"rendered":"Home"},"content":{"rendered":"
\n
\n
\n\n

SPECIALIZED EXPERTISE
IMPACTFUL INVESTMENTS<\/h1>\n\n\n\n

A fund accelerating breakthroughs in blood and cellular
therapies and supporting technologies<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n\n

\n
\n\n
NYBC Ventures elevates investment performance by leveraging New York Blood Center\u2019s unparalleled expertise in blood and cellular therapies.<\/h6>\n\n<\/div>\n<\/div>\n\n
\n\n

AREAS OF FOCUS<\/h2>\n\n<\/div>\n\n
\n
\n\n
\"\"<\/figure>\n\n\n\n

HEMATOLOGY<\/h4>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n\n

TRANSFUSION
MEDICINE<\/h4>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n\n

CELL THERAPY<\/h4>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n\n

INFECTIOUS
DISEASE<\/h4>\n\n<\/div><\/div>\n<\/div>\n\n
\n
\n\n

INVESTMENT TEAM<\/h2>\n\n\n\n

A dedicated team of professional investors driven by a passion for supporting innovation, visionary founders, and exceptional companies.<\/p>\n\n<\/div>\n<\/div>\n\n

\n
\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

CHRISTOPHER D.
HILLYER MD<\/h4>\n\n\n\n

GENERAL PARTNER<\/h5>\n\n\n\n
MANAGER<\/h5>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

JAY MOHR<\/h4>\n\n\n\n

GENERAL PARTNER<\/h5>\n\n\n\n
MANAGER<\/h5>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

MEG WOOD, MPH<\/h4>\n\n\n\n

MANAGING DIRECTOR<\/h5>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

KUAN YU<\/h4>\n\n\n\n

SR ANALYST<\/h5>\n\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n
\n\n

BOARD OF MANAGERS<\/h3>\n\n\n
\n
\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

JOHN ROSENTHAL<\/h4>\n\n\n\n

CHAIR<\/h5>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

JUNG CHOI<\/h4>\n\n\n\n

MANAGER<\/h5>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

CRISTINA CSIMMA<\/h4>\n\n\n\n

MANAGER<\/h5>\n\n<\/div>\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n\n
\n\n

DAVID KABAKOFF<\/h4>\n\n\n\n

MANAGER<\/h5>\n\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n
\n\n

PORTFOLIO<\/h2>\n\n\n\n

Our investment strategy targets promising early to mid stage innovations in blood and cellular therapies and related technologies. We support therapeutics, devices, and other breakthrough solutions that address key challenges in our fields of interest.<\/p>\n\n\n

\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n\n
\n\n
\"\"<\/a><\/figure>\n\n<\/div><\/div>\n<\/div>\n<\/div>\n\n
\n\n

ABOUT<\/h2>\n\n\n\n

NYBC Ventures, launched by the New York Blood Center Enterprises (NYBCe)<\/strong><\/a> with a $50M commitment, drives innovation in blood-related fields, cellular therapies, and related technologies to improve patient lives. For over 60 years, the New York Blood Center has provided top-quality blood products and transfusion services. It research arm, the Lindsley F. Kimball Research Institute (LFKRI)<\/a><\/strong>, one of the world’s preeminent blood research organizations conducting foundational, epidemiologic, and clinical research. Comprehensive Cell Solutions (CCS)<\/a><\/strong>, is a cell and gene therapy-focused development and manufacturing organization that provides critical capacity to an underserved population of early-stage developers, as well as expertise and strategic footprint for hospital treatment centers and pharmaceuticals organizations.<\/p>\n\n<\/div>","protected":false},"excerpt":{"rendered":"

SPECIALIZED EXPERTISEIMPACTFUL INVESTMENTS A fund accelerating breakthroughs in blood and cellulartherapies and supporting technologies NYBC Ventures elevates investment performance by leveraging New York Blood Center\u2019s unparalleled expertise in blood and cellular therapies. AREAS OF FOCUS INVESTMENT TEAM A dedicated team of professional investors driven by a passion for supporting innovation, visionary founders, and exceptional companies. … Read more<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-8","page","type-page","status-publish"],"yoast_head":"\nHome - NYBC Ventures<\/title>\n<meta name=\"description\" content=\"Learn more about our investment strategy targeting early to mid-stage innovations in blood and cellular therapies and related technologies.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Home - NYBC Ventures\" \/>\n<meta property=\"og:description\" content=\"Learn more about our investment strategy targeting early to mid-stage innovations in blood and cellular therapies and related technologies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www-stg.nybcventures.com\/\" \/>\n<meta property=\"og:site_name\" content=\"NYBC Ventures\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-13T19:06:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www-stg.nybcventures.com\/\",\"url\":\"https:\/\/www-stg.nybcventures.com\/\",\"name\":\"Home - NYBC Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/www-stg.nybcventures.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www-stg.nybcventures.com\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www-stg.nybcventures.com\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png\",\"datePublished\":\"2024-09-12T19:47:02+00:00\",\"dateModified\":\"2024-11-13T19:06:20+00:00\",\"description\":\"Learn more about our investment strategy targeting early to mid-stage innovations in blood and cellular therapies and related technologies.\",\"breadcrumb\":{\"@id\":\"https:\/\/www-stg.nybcventures.com\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www-stg.nybcventures.com\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www-stg.nybcventures.com\/#primaryimage\",\"url\":\"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png\",\"contentUrl\":\"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png\",\"width\":300,\"height\":388},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www-stg.nybcventures.com\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www-stg.nybcventures.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www-stg.nybcventures.com\/#website\",\"url\":\"https:\/\/www-stg.nybcventures.com\/\",\"name\":\"NYBC Ventures\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www-stg.nybcventures.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www-stg.nybcventures.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www-stg.nybcventures.com\/#organization\",\"name\":\"NYBC Ventures\",\"url\":\"https:\/\/www-stg.nybcventures.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www-stg.nybcventures.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/NYBCV_2c.svg\",\"contentUrl\":\"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/NYBCV_2c.svg\",\"caption\":\"NYBC Ventures\"},\"image\":{\"@id\":\"https:\/\/www-stg.nybcventures.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Home - NYBC Ventures","description":"Learn more about our investment strategy targeting early to mid-stage innovations in blood and cellular therapies and related technologies.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Home - NYBC Ventures","og_description":"Learn more about our investment strategy targeting early to mid-stage innovations in blood and cellular therapies and related technologies.","og_url":"https:\/\/www-stg.nybcventures.com\/","og_site_name":"NYBC Ventures","article_modified_time":"2024-11-13T19:06:20+00:00","og_image":[{"url":"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www-stg.nybcventures.com\/","url":"https:\/\/www-stg.nybcventures.com\/","name":"Home - NYBC Ventures","isPartOf":{"@id":"https:\/\/www-stg.nybcventures.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www-stg.nybcventures.com\/#primaryimage"},"image":{"@id":"https:\/\/www-stg.nybcventures.com\/#primaryimage"},"thumbnailUrl":"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png","datePublished":"2024-09-12T19:47:02+00:00","dateModified":"2024-11-13T19:06:20+00:00","description":"Learn more about our investment strategy targeting early to mid-stage innovations in blood and cellular therapies and related technologies.","breadcrumb":{"@id":"https:\/\/www-stg.nybcventures.com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www-stg.nybcventures.com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www-stg.nybcventures.com\/#primaryimage","url":"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png","contentUrl":"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/nybcv_af_bh_1.png","width":300,"height":388},{"@type":"BreadcrumbList","@id":"https:\/\/www-stg.nybcventures.com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www-stg.nybcventures.com\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/www-stg.nybcventures.com\/#website","url":"https:\/\/www-stg.nybcventures.com\/","name":"NYBC Ventures","description":"","publisher":{"@id":"https:\/\/www-stg.nybcventures.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www-stg.nybcventures.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www-stg.nybcventures.com\/#organization","name":"NYBC Ventures","url":"https:\/\/www-stg.nybcventures.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www-stg.nybcventures.com\/#\/schema\/logo\/image\/","url":"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/NYBCV_2c.svg","contentUrl":"https:\/\/www-stg.nybcventures.com\/wp-content\/uploads\/2024\/09\/NYBCV_2c.svg","caption":"NYBC Ventures"},"image":{"@id":"https:\/\/www-stg.nybcventures.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www-stg.nybcventures.com\/index.php?rest_route=\/wp\/v2\/pages\/8","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www-stg.nybcventures.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www-stg.nybcventures.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www-stg.nybcventures.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www-stg.nybcventures.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8"}],"version-history":[{"count":0,"href":"https:\/\/www-stg.nybcventures.com\/index.php?rest_route=\/wp\/v2\/pages\/8\/revisions"}],"wp:attachment":[{"href":"https:\/\/www-stg.nybcventures.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}